In Friday’s Wall Street session, Pacific Biosciences of California Inc (NASDAQ:PACB) shares traded at $1.33, up 2.31% from the previous session.
PACB stock price is now -20.05% away from the 50-day moving average and -24.24% away from the 200-day moving average. The market capitalization of the company currently stands at $364.24M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
, while ‘JP Morgan’ rates the stock as ‘Neutral’
In other news, HENRY CHRISTIAN O, insider sold 12,497 shares of the company’s stock on Mar 03 ’25. The stock was sold for $17,583 at an average price of $1.41. Upon completion of the transaction, the insider now directly owns 2,225,357 shares in the company, valued at $2.96 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 03 ’25, Van Oene Mark sold 6,486 shares of the business’s stock. A total of $9,126 was realized by selling the stock at an average price of $1.41. This leaves the insider owning 1,497,695 shares of the company worth $1.99 million. A total of 11.08% of the company’s stock is owned by insiders.
During the past 12 months, Pacific Biosciences of California Inc has had a low of $1.16 and a high of $5.01. As of last week, the company has a debt-to-equity ratio of 1.32, a current ratio of 12.63, and a quick ratio of 11.13.
The net profit margin was -200.40% and return on equity was -51.05% for PACB. The company reported revenue of $39.97 million for the quarter, compared to $55.69 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -28.23 percent.
